Ten‐Year Trajectory of Potentially Inappropriate Medications in Very Old Women: Importance of Cognitive Status
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Objectives: To determine which older adults tend to receive potentially inappropriate medications ( PIM s), how this may differ according to cognitive status, and how the trajectories of PIM use change over time. Design: Ten‐year longitudinal cohort study. Setting: Three clinical sites in the U nited S tates. Participants: One thousand four hundred eighty‐four community‐dwelling women aged 75 and older. Measurements: At follow‐up, cognitive status was ascertained and classified as normal, mild cognitive impairment ( MCI ), or dementia. Beers 2003 criteria and other literature were used to identify PIM s from detailed medication inventory performed at three time points. Anticholinergic load was measured using the A nticholinergic C ognitive B urden S cale ( ACB ), which assigns medications a value from 0 to 3 depending on anticholinergic properties. Results: At baseline, 23.9% of women were taking at least one PIM and the mean ± SD ACB score was 1.41 ± 1.69. The most frequently reported PIM s were anticholinergics (15.2%), benzodiazepines (8.6%), and antispasmodics (8.0%). Over 10 years, PIM use increased for women with dementia (24.9–33.1%; P = .02) but remained fairly constant for women with MCI (23.9–23.0%; P = .84) and normal cognitive status (22.2–19.8%; P = .17). Mean ACB score increased significantly ( P < .001) over time for all groups (dementia: 1.28–2.05; MCI : 0.98–1.66; normal: 0.99–1.48). Conclusion: PIM use and anticholinergic load in a community‐dwelling population of older women was high, especially in women who later developed dementia. Future guidelines should limit PIM use and seek safer alternatives.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fick, D. M., Cooper, J. W., Wade, W. E., Waller, J. L., Maclean, J. R., & Beers, M. H. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.22.2716 · Cited by 2,389 · cited 3×
“Many PIMs can contribute to other comorbidities and impair cognitive function.(1) Age-related changes in pharmacokinetics and pharmacodynamics can also contribute to potentially harmful adverse effects, and multiple medication use can lead to drug–drug and drug–disease interactions.”
BackgroundMethodInfluentialImpact of Anticholinergics on the Aging Brain: A Review and Practical Application
Boustani, M., Campbell, N., Munger, S., Maidment, I., & Fox, C. (2008) · Aging Health · doi:10.2217/1745509x.4.3.311 · Cited by 862
Fox, C., Richardson, K., Maidment, I. D., Savva, G. M., Matthews, F. E., Smithard, D., Coulton, S., Katona, C., Boustani, M. A., & Brayne, C. (2011) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2011.03491.x · Cited by 655
Cognitive Effects of Long-Term Benzodiazepine Use: A Meta-Analysis
Barker, M. J., Greenwood, K. M., Jackson, M., & Crowe, S. F. (2004) · CNS Drugs · doi:10.2165/00023210-200418010-00004 · Cited by 552
The cognitive impact of anticholinergics: A clinical review
Malaz Boustani, M. (2009) · Clinical Interventions in Aging · doi:10.2147/cia.s5358 · Cited by 479
Risk profiles for mild cognitive impairment and progression to dementia are gender specific
Artero, S., Ancelin, M.-L., Portet, F., Dupuy, A., Berr, C., Dartigues, J.-F., Tzourio, C., Rouaud, O., Poncet, M., Pasquier, F., et al. (2008) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2007.136903 · Cited by 281 · cited 1×
“In addition, the cognitive effects of anticholinergic use may be sex specific.(30) In a population of women aged 85 and older at follow-up, with more than 40% with dementia or MCI, approximately one-quarter reported taking at least one PIM.”
BackgroundUse of anticholinergics and the risk of cognitive impairment in an African American population
Campbell, N. L., Boustani, M. A., Lane, K. A., Gao, S., Hendrie, H., Khan, B. A., Murrell, J. R., Unverzagt, F. W., Hake, A., Smith-Gamble, V., et al. (2010) · Neurology · doi:10.1212/wnl.0b013e3181e7f2ab · Cited by 194 · cited 1×
“The scale was developed through a systematic review by an interdisciplinary panel and validated in subsequent studies.(8,14)”
Method
Cited by
Salahudeen, M. S., Duffull, S. B., & Nishtala, P. S. (2015) · BMC Geriatrics · doi:10.1186/s12877-015-0029-9 · Cited by 547
Treatment of Benzodiazepine Dependence
Soyka, M. (2017) · New England Journal of Medicine · doi:10.1056/nejmra1611832 · Cited by 465
Fox, C., Smith, T., Maidment, I., Chan, W.-Y., Bua, N., Myint, P. K., Boustani, M., Kwok, C. S., Glover, M., Koopmans, I., et al. (2014) · Age and Ageing · doi:10.1093/ageing/afu096 · Cited by 336
Gray, S. L., Dublin, S., Yu, O., Walker, R., Anderson, M., Hubbard, R. A., Crane, P. K., & Larson, E. B. (2016) · BMJ · doi:10.1136/bmj.i90 · Cited by 233
Salahudeen, M. S., Hilmer, S. N., & Nishtala, P. S. (2015) · Journal of the American Geriatrics Society · doi:10.1111/jgs.13206 · Cited by 189
Metadata
- Authors
- Koyama, A., Steinman, M., Ensrud, K., Hillier, T. A., & Yaffe, K.
- Venue
- Journal of the American Geriatrics Society
- Publisher
- Wiley
- Published
- 2013-01-15
- Volume
- 61
- Issue
- 2
- Pages
- 258-263
- ISSN
- 0002-8614 (ISSN-L)
- 1532-5415
- OpenAlex
- W1983392865
- Cited by
- 52
- References
- 7
- FWCI
- 2.48
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.